|AVN...PRIORITY REVIEW- GRANTED BY THE FDA!!! |
Breaking news just out & over the wire!!!
No wonder the short bashers are in a nervouse frenzy!!!
AVN's potential multi-billion dollar blockuster drug, Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA!!!
LOAD UP!!!! The shares are still way cheap!!!
"The FDA has granted AVANIR's NDA a Priority Review, which is an accelerated six-month review timeline."
Insider Buying / * AVN CEO Aquires 2M Shares*~
This is extremely BULLISH and the short bashers are in a nervous frenzy!
YAKATAN, GERALD J.: Declared Holdings
Company/Relationship Reported Shares Ownership
Chief Executive Officer
8-Mar-05 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per
(Value of $5,300,000)
Also, biotech guru, Jonathan Silverman recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares.
Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
blockbuster drug in Phase 3 with remarkable results up for FDA
Priority Approval, fantastic Anthrax Antibody, unique Cancer
Compound unlike anything ever seen before, IgE for allergies and
asthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-
cholestoral drug, Xenerex subsidiary for the production of the only
completely human mABs.
Share This Post: